Bottom line
Is TRIEX a good fund? The bottom line
TRIEX is the Retirement Class share class of Nuveen International Equity Index Fund, an index international stock mutual fund from Nuveen / TIAA.
Its expense ratio is 0.3% — about $30 a year on every $10,000 invested, cheaper than 90% of international stock funds we track.
It returned +31.3% over one year, +8.8% a year over five years, +8.1% a year over ten (as of Dec 31, 2025, per its prospectus).
With $35.9 billion in net assets and 700 holdings, its largest position is ASML Holding NV (2.9%) and the top 10 make up 13.8% of the portfolio.
What stands out
- Low cost: cheaper than 90% of international stock peers
- 5-year return beat 73% of category peers
- Broadly diversified (700 holdings)
- No front-end sales load
- Large and established ($35.9 billion)
Updated Nov 19, 2026
What TRIEX invests in
The Fund seeks a favorable long-term total return, mainly through capital appreciation, by investing primarily in a portfolio of foreign equity investments based on a market index.
Under normal circumstances, the Fund invests at least 80% of its assets in securities of its benchmark index, the MSCI EAFE (Europe, Australasia, Far East) Index (the MSCI EAFE Index). The MSCI EAFE Index is designed to measure equity market performance in developed markets around the world, excluding the U.S. and Canada. The Fund buys most, but not necessarily all, of the stocks included in its benchmark index, and will attempt to closely match the overall investment characteristics of its benchmark index. For purposes of the 80% investment policy, the term assets means net assets, plus the amount of any borrowings for investment purposes. The Fund is designed to track various foreign equity markets as a whole or a segment of these markets. The Fund primarily invests its assets in equity securities its sub-adviser, Nuveen Asset Management, LLC (Nuveen Asset Management), has selected…
From the fund's prospectus (filed Aug 3, 2026).
TRIEX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| TRIEX | +31.3% | +8.8% | +8.1% |
| International Stock median | +25.5% | +6.4% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2025
What TRIEX costs
On a $10,000 investment, TRIEX's 0.3% expense ratio costs about $30 a year. The prospectus estimates $381 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
TRIEX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | ASML Holding NV | 2.88% |
| 2 | HSBC Holdings PLC | 1.65% |
| 3 | Roche Holding AG | 1.38% |
| 4 | Novartis AG | 1.29% |
| 5 | Nestle SA | 1.16% |
| 6 | Shell PLC | 1.16% |
| 7 | AstraZeneca PLC | 1.15% |
| 8 | Siemens AG | 1.10% |
| 9 | Mitsubishi UFJ Financial Group Inc | 1.07% |
| 10 | BHP Group Ltd | 0.97% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 13.8% of the fund. See all top 25 holdings and asset mix →